Literature DB >> 10584603

Screening for gynecologic cancer.

K M Zanotti1, A W Kennedy.   

Abstract

Screening for cervical cancer with the Pap test has significantly reduced mortality from the disease. Although screening for ovarian and endometrial cancer is desirable, suggested strategies have not demonstrated efficacy. For the present time, educating patients with regard to the symptoms associated with these diseases and prompt evaluation of women who present with these symptoms helps limit unnecessary diagnostic delay.

Entities:  

Mesh:

Year:  1999        PMID: 10584603     DOI: 10.1016/s0025-7125(05)70175-9

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

1.  Promoting gynecologic cancer awareness at a critical juncture--where women and providers meet.

Authors:  Crystale Purvis Cooper; Cynthia A Gelb; Juan Rodriguez; Nikki A Hawkins
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

2.  Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

Authors:  K Oikonomopoulou; L Li; Y Zheng; I Simon; R L Wolfert; D Valik; M Nekulova; M Simickova; T Frgala; E P Diamandis
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.